Literature DB >> 1310732

Interactions between Trichomonas vaginalis and vaginal flora in a mouse model.

K C Meysick1, G E Garber.   

Abstract

To study the role of vaginal flora and pH in the pathogenesis of Trichomonas vaginalis, an intravaginal mouse model of infection was established. By employing this model, the vaginal flora and pH of mice could be monitored for changes caused by the parasite. As a baseline, the endemic vaginal flora of BALB/c mice was examined first and found to consist mainly of Staphylococcus aureus and Enterococcus species (32-76%). Lactobacilli and enteric bacilli were moderate (16-32%) in their frequency of isolation, and the prevalence of both anaerobic species and coagulase-negative staphylococci was low (4-16%). Vaginal pH was recorded at 6.5 +/- 0.3. Estrogenization, which was required for a sustained T. vaginalis infection, did not significantly alter vaginal flora; however, a slight rise in the number of bacterial species isolated per mouse and a drop in vaginal pH (6.2 +/- 0.5) were observed. Trichomonas vaginalis-infected mice did not appear to show significant changes in vaginal flora although vaginal pH was slightly increased. This mouse model could have applications in both immunologic and pathogenic studies of T. vaginalis and, with further modifications, aid in the study of protist-bacterial interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310732

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  18 in total

Review 1.  Clinical and microbiological aspects of Trichomonas vaginalis.

Authors:  D Petrin; K Delgaty; R Bhatt; G Garber
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Mouse intravaginal infection with Trichomonas vaginalis and role of Lactobacillus acidophilus in sustaining infection.

Authors:  T McGrory; G E Garber
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 3.  Comparative aspects of immunity and vaccination in human and bovine trichomoniasis: a review.

Authors:  Aspinas Chapwanya; Abubakar Yusha'u Usman; Pete Charles Irons
Journal:  Trop Anim Health Prod       Date:  2015-09-30       Impact factor: 1.559

4.  Profile of Candida albicans-secreted aspartic proteinase elicited during vaginal infection.

Authors:  Brad N Taylor; Peter Staib; Ayfer Binder; Antje Biesemeier; Miriam Sehnal; Martin Röllinghoff; Joachim Morschhäuser; Klaus Schröppel
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection.

Authors:  M C Abraham; M Desjardins; L G Filion; G E Garber
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

6.  A Murine Model of Group B Streptococcus Vaginal Colonization.

Authors:  Kathryn A Patras; Kelly S Doran
Journal:  J Vis Exp       Date:  2016-11-16       Impact factor: 1.355

7.  A Chinese rhesus macaque (Macaca mulatta) model for vaginal Lactobacillus colonization and live microbicide development.

Authors:  Rosa R Yu; Andrew T Cheng; Laurel A Lagenaur; Wenjun Huang; Deborah E Weiss; Jim Treece; Brigitte E Sanders-Beer; Dean H Hamer; Peter P Lee; Qiang Xu; Yang Liu
Journal:  J Med Primatol       Date:  2009-04       Impact factor: 0.667

8.  Murine vaginal colonization model for investigating asymptomatic mucosal carriage of Streptococcus pyogenes.

Authors:  Michael E Watson; Hailyn V Nielsen; Scott J Hultgren; Michael G Caparon
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

9.  Mouse estrous cycle regulation of vaginal versus uterine cytokines, chemokines, α-/β-defensins and TLRs.

Authors:  Danica K Hickey; John V Fahey; Charles R Wira
Journal:  Innate Immun       Date:  2012-08-01       Impact factor: 2.680

10.  Exogenous Reproductive Hormones nor Candida albicans Colonization Alter the Near Neutral Mouse Vaginal pH.

Authors:  Jian Miao; Hubertine M E Willems; Brian M Peters
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.